PATRICIA RAINALDI: Open Payments
NPI 1083902902 · NEW WINDSOR, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 13 payments from 10 companies in 2025. Trend: 2023 $1,189 · 2024 $1,216 · 2025 $1,227
Food & beverage: $1,173Education: $54
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $283 |
| ALK-Abello, Inc | 1 | $129 |
| GENZYME CORPORATION | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $121 |
| Novo Nordisk Inc | 1 | $118 |
| Novartis Pharmaceuticals Corporation | 1 | $82 |
| AstraZeneca Pharmaceuticals LP | 1 | $65 |
| Medtronic, Inc. | 2 | $54 |
Products named: Auvelity, Odactra, DUPIXENT, VRAYLAR, ZEPBOUND, Wegovy, LEQVIO, FASENRA.
Industry payments across NY — which companies pay providers there.
